ÁNGEL
GIL HERNÁNDEZ
Forscher seit 2023
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (United Kingdom) (1)
2007
-
Immunogenicity and safety of three doses of a bivalent (B : 4 : P1.19,15 and B : 4 : P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents
CLINICAL AND VACCINE IMMUNOLOGY, Vol. 14, Núm. 1, pp. 65-73